HEALTH CARE SECTOR

BIOTECHNOLOGY INDUSTRY

AEGR

aegerion pharmaceuticals inc
(AEGR:NASDAQ GS)

Last $61.57 USD

Change Today -0.13 / -0.21%

Volume 1.8M

AEGR On Other Exchanges

Symbol

Exchange

AEGR:US

NASDAQ GS

As of 8:10 PM 05/17/13 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - AEGERION PHARMACEUTICALS INC (AEGR)

Aegerion Pharmaceuticals, Inc. to Report Q1, 2013 on Apr 30, 2013

CapIQ 04/30/2013 4:00 AM ET

Aegerion Pharmaceuticals, Inc. to Report Q3, 2012 on Nov 07, 2012

CapIQ 04/30/2013 4:00 AM ET

Aegerion Pharmaceuticals, Inc. to Report Q2, 2012 on Aug 08, 2012

CapIQ 04/30/2013 4:00 AM ET

2012 revenues at Aegerion Pharmaceuticals, Inc. totaled $0.0 USD, while annual losses equaled $2.58 per share.

Quarterly Earnings & Estimates - AEGERION PHARMACEUTICALS INC (AEGR)

Actuals vs. Estimates for AEGERION PHARMACEUTICALS INC AEGR

Aegerion Pharmaceuticals, Inc.'s Quarterly Earnings

Aegerion Pharmaceuticals, Inc. reported 1st quarter 2013 losses of $0.64 per share on 05/2/2013.

Annual Earnings & Estimates - AEGERION PHARMACEUTICALS INC (AEGR)

Aegerion Pharmaceuticals, Inc.'s Annual Earnings

Aegerion Pharmaceuticals, Inc. reported annual 2012 losses of $2.58 per share on 03/8/2013.

Quarterly Revenues - AEGERION PHARMACEUTICALS INC (AEGR)

Chart not available

Aegerion Pharmaceuticals, Inc.'s Quarterly Revenues

Aegerion Pharmaceuticals, Inc. had 1st quarter 2013 revenues of $1.2M USD. This bettered the $726.5K USD consensus of the 7 analysts covering the company.

Annual Revenues - AEGERION PHARMACEUTICALS INC (AEGR)

Aegerion Pharmaceuticals, Inc.'s Annual Revenues

Aegerion Pharmaceuticals, Inc. did not report revenues for the full year 2012. However, during the prior year the company reported revenues of $0.0 USD.